Cargando…
Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines
While many fertility preservation (FP) options now exist for reproductive-aged cancer patients, access to these services continues to be limited. A comprehensive FP program should be organized to serve oncofertility patients effectively. Also, much effort is needed from various individuals—patients,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Reproductive Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783912/ https://www.ncbi.nlm.nih.gov/pubmed/29376012 http://dx.doi.org/10.5653/cerm.2017.44.4.171 |
_version_ | 1783295352623857664 |
---|---|
author | Kim, Jayeon Kim, Seul Ki Hwang, Kyung Joo Kim, Seok Hyun |
author_facet | Kim, Jayeon Kim, Seul Ki Hwang, Kyung Joo Kim, Seok Hyun |
author_sort | Kim, Jayeon |
collection | PubMed |
description | While many fertility preservation (FP) options now exist for reproductive-aged cancer patients, access to these services continues to be limited. A comprehensive FP program should be organized to serve oncofertility patients effectively. Also, much effort is needed from various individuals—patients, specialists from various fields, and consultants—to facilitate FP in a timely manner. Various challenges still exist in improving access to FP programs. To improve access to FP treatment, it is important to educate oncologists and patients via electronic tools and to actively navigate patients through the system. Reproductive endocrinology practices that receive oncofertility referrals must be equipped to provide a full range of options on short notice. A multidisciplinary team approach is required, involving physicians, nurses, mental health professionals, office staff, and laboratory personnel. The bottom line of FP patient care is to understand the true nature of each patient's specific situation and to develop a patient flow system that will help build a successful FP program. Expanding the patient flow system to all comprehensive cancer centers will ensure that all patients are provided with adequate information regarding their fertility, regardless of geography. |
format | Online Article Text |
id | pubmed-5783912 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Korean Society for Reproductive Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-57839122018-01-26 Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines Kim, Jayeon Kim, Seul Ki Hwang, Kyung Joo Kim, Seok Hyun Clin Exp Reprod Med Review While many fertility preservation (FP) options now exist for reproductive-aged cancer patients, access to these services continues to be limited. A comprehensive FP program should be organized to serve oncofertility patients effectively. Also, much effort is needed from various individuals—patients, specialists from various fields, and consultants—to facilitate FP in a timely manner. Various challenges still exist in improving access to FP programs. To improve access to FP treatment, it is important to educate oncologists and patients via electronic tools and to actively navigate patients through the system. Reproductive endocrinology practices that receive oncofertility referrals must be equipped to provide a full range of options on short notice. A multidisciplinary team approach is required, involving physicians, nurses, mental health professionals, office staff, and laboratory personnel. The bottom line of FP patient care is to understand the true nature of each patient's specific situation and to develop a patient flow system that will help build a successful FP program. Expanding the patient flow system to all comprehensive cancer centers will ensure that all patients are provided with adequate information regarding their fertility, regardless of geography. The Korean Society for Reproductive Medicine 2017-12 2017-12-31 /pmc/articles/PMC5783912/ /pubmed/29376012 http://dx.doi.org/10.5653/cerm.2017.44.4.171 Text en Copyright © 2017. The Korean Society for Reproductive Medicine http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Kim, Jayeon Kim, Seul Ki Hwang, Kyung Joo Kim, Seok Hyun Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines |
title | Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines |
title_full | Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines |
title_fullStr | Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines |
title_full_unstemmed | Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines |
title_short | Fertility preservation during cancer treatment: The Korean Society for Fertility Preservation clinical guidelines |
title_sort | fertility preservation during cancer treatment: the korean society for fertility preservation clinical guidelines |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783912/ https://www.ncbi.nlm.nih.gov/pubmed/29376012 http://dx.doi.org/10.5653/cerm.2017.44.4.171 |
work_keys_str_mv | AT kimjayeon fertilitypreservationduringcancertreatmentthekoreansocietyforfertilitypreservationclinicalguidelines AT kimseulki fertilitypreservationduringcancertreatmentthekoreansocietyforfertilitypreservationclinicalguidelines AT hwangkyungjoo fertilitypreservationduringcancertreatmentthekoreansocietyforfertilitypreservationclinicalguidelines AT kimseokhyun fertilitypreservationduringcancertreatmentthekoreansocietyforfertilitypreservationclinicalguidelines |